Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Clinical trial NCT01309932 · COMPLETED
Trial details
- NCT number
- NCT01309932
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-07-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.